Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
The invention provides a composition for promoting regeneration of tissue which has degenerated in a subject as a result of a disease or disorder and a method of using the composition is provided. The composition comprises a biodegradable acellular matrix, and passaged autologous fibroblasts substantially free of immunogenic proteins, e.g., culture medium serum-derived proteins, integrated within the matrix. Also provided is an injectable composition comprising an acellular filler material (e.g., any type of collagen) and passaged autologous fibroblasts substantially free of immunogenic proteins, e.g., culture medium serum-derived proteins, for correcting defects in skin, such as wrinkles or scars, and for augmenting tissue in the subject, particularly facial tissue.
1. A method of repairing bone tissue in a subject with a bone defect, wherein said method comprises:
a) providing a composition,
wherein the composition comprises (i) a biodegradable acellular matrix and (ii) autologous fibroblasts,
wherein the composition is substantially free of proteins derived from xenogeneic serum of xenogeneic serum-containing culture medium,
wherein said biodegradable acellular matrix, prior to combination with said autologous fibroblasts, comprises one or more substances selected from the group consisting of collagen, glycosaminoglycans, gelatin, polyglycolic acid, cat gut, demineralized bone, hydroxyapatite, and anorganic bone, and
wherein and said autologous fibroblasts are added to the matrix at high density and then cultured for up to 4 days, such that sufficient autologous fibroblasts integrate within said biodegradable acellular matrix to substantially fill the space on and within said biodegradable acellular matrix available for cells;
b) identifying a site of a bone defect in said subject; and
c) placing the composition on the site so that said bone defect is repaired.
2. The method of claim 1 , wherein the bone defect is a dental ridge defect.
3. The method of claim 1 , wherein the bone defect is a defect of a mandibular bone.
4. The method of claim 1 , wherein the bone defect is a defect of a maxillary bone.
5. The method of claim 1 , wherein the bone defect is a defect of a bone selected from the group consisting of an orbital bone, a zygomatic bone, a cranial bone, or a nasal bone.
6. The method of claim 1 , wherein the bone defect is a sinus floor defect.
7. The method of claim 1 , wherein the bone defect is a non-union defect.
8. The method of claim 7 , wherein the non-union defect is a non-union defect of a long bone.
9. The method of claim 1 , wherein said biodegradable matrix, prior to combination with said autologous fibroblasts, comprises collagen and glycosaminoglycans, the collagen being cross-linked to the glycosaminoglycans with glutaraldehyde.
10. The method of claim 1 , wherein said one or more substances are selected from the group consisting of gelatin, polyglycolic acid, cat gut sutures, demineralized bone, and hydroxyapatite.
11. The method of claim 1 , wherein said autologous fibroblasts are from gums, palate, or skin of said subject.
12. The method of claim 1 , wherein said one or more substances comprise anorganic bone.
13. The method of claim 12 , said one or more substances further comprising collagen.
14. The method of claim 1 , wherein the collagen is bovine collagen.
15. The method of claim 1 , wherein the collagen is porcine collagen type I or porcine collagen type III.
16. The method of claim 1 , wherein said autologous fibroblasts, after being added to the matrix at high density, are cultured for 3 to 4 days.